147 related articles for article (PubMed ID: 15140405)
21. Mechanisms of action of taxanes in prostate cancer.
Stein CA
Semin Oncol; 1999 Oct; 26(5 Suppl 17):3-7. PubMed ID: 10604261
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.
Steele VE; Arnold JT; Lei H; Izmirlian G; Blackman MR
Anticancer Res; 2006; 26(5A):3205-15. PubMed ID: 17094431
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling reveals novel targets of estramustine phosphate in prostate cancer cells.
Hong X; Li Y; Hussain M; Sarkar FH
Cancer Lett; 2004 Jun; 209(2):187-95. PubMed ID: 15159021
[TBL] [Abstract][Full Text] [Related]
25. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer.
Koike H; Ito K; Takezawa Y; Oyama T; Yamanaka H; Suzuki K
Br J Cancer; 2005 Apr; 92(8):1538-44. PubMed ID: 15846301
[TBL] [Abstract][Full Text] [Related]
27. Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.
Ramachandran K; Gopisetty G; Gordian E; Navarro L; Hader C; Reis IM; Schulz WA; Singal R
Cancer Res; 2009 Feb; 69(4):1527-35. PubMed ID: 19190346
[TBL] [Abstract][Full Text] [Related]
28. Molecular impacts of antisense complementary to the liver fatty acid binding protein (FABP) mRNA in DU 145 prostate cancer cells in vitro.
Hammamieh R; Chakraborty N; Das R; Jett M
J Exp Ther Oncol; 2004 Oct; 4(3):195-202. PubMed ID: 15724839
[TBL] [Abstract][Full Text] [Related]
29. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
Pulukuri SM; Rao JS
Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979
[TBL] [Abstract][Full Text] [Related]
30. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
31. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.
Shaikh IA; Brown I; Schofield AC; Wahle KW; Heys SD
Prostate; 2008 Nov; 68(15):1635-46. PubMed ID: 18668525
[TBL] [Abstract][Full Text] [Related]
32. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
[TBL] [Abstract][Full Text] [Related]
33. Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer.
Eigl BJ; Eggener SE; Baybik J; Ettinger S; Chi KN; Nelson C; Wang Z; Gleave ME
Clin Cancer Res; 2005 Jul; 11(13):4905-11. PubMed ID: 16000589
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism of inhibiting the proliferation of prostate cancer by finasteride: a study using cDNA microarray].
Chen G; Geng J; Zhang YF
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1489-92. PubMed ID: 16061029
[TBL] [Abstract][Full Text] [Related]
35. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
[TBL] [Abstract][Full Text] [Related]
36. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
Reyes I; Tiwari R; Geliebter J; Reyes N
Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
[TBL] [Abstract][Full Text] [Related]
37. Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cells.
Montgomery RB; Bonham M; Nelson PS; Grim J; Makary E; Vessella R; Stahl WL
Prostate; 2005 Oct; 65(2):141-50. PubMed ID: 15924336
[TBL] [Abstract][Full Text] [Related]
38. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer.
Sun A; Shanmugam I; Song J; Terranova PF; Thrasher JB; Li B
Prostate; 2007 Jun; 67(9):976-88. PubMed ID: 17440966
[TBL] [Abstract][Full Text] [Related]
39. Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3.
Muenchen HJ; Poncza PJ; Pienta KJ
Urology; 2001 Feb; 57(2):366-70. PubMed ID: 11182366
[TBL] [Abstract][Full Text] [Related]
40. Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo.
Gonzalez-Moreno O; Segura V; Serrano D; Nguewa P; de las Rivas J; Calvo A
Int J Cancer; 2007 Sep; 121(6):1197-204. PubMed ID: 17520673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]